Skip to main content

SBIO Continues Rally on Breakthrough Drug Data

The ALPS Medical Breakthroughs ETF (SBIO) rallied 11.53% last week on positive trial data and merger and acquisition news that revived the biotech sector. The small- and mid-cap biotech companies among SBIO’s holdings outperformed large-cap biotech indexes by nearly 200 bps last week on positive...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.